Brevan Howard Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,524
Closed -$144K 1113
2024
Q2
$144K Buy
+17,524
New +$144K ﹤0.01% 886